J.L. Bainbridge & Co’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-409,085
Closed -$40.6M 96
2019
Q3
$40.6M Buy
+409,085
New +$38.9M 6.07% 7

Other funds holding CELG

J.L. Bainbridge & Co's CELG Position: Q4 2019 in Review

J.L. Bainbridge & Co sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 409,085 shares — an estimated $40.6M sold.

J.L. Bainbridge & Co first reported a position in CELG in Q3 2019 and held it in 1 quarter. The position peaked at $40.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • J.L. Bainbridge & Co reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • J.L. Bainbridge & Co sold 409,085 Celgene Corp shares in Q4 2019, an estimated $40.6M.
  • J.L. Bainbridge & Co first reported a position in Celgene Corp in Q3 2019 and held it in 1 quarter.
  • J.L. Bainbridge & Co's Celgene Corp position peaked at $40.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on J.L. Bainbridge & Co's 13F filing for Q4 2019, filed 13 Feb 2020.